p53 mutations in stromal fibroblasts sensitize tumors against chemotherapy

International Journal of Cancer

Volumn 123, Issue 4, 2008, Pages 967-971

  Lafkas, Daniel ^a   Trimis, George ^a   Papavassiliou, Athanasios G ^a   Kiaris, Hippokratis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chemotherapy; Fibroblasts; p53; Senescence; Stroma

Indexed keywords

CISPLATIN; DOXORUBICIN; GROWTH FACTOR; PROTEIN P53; ANTINEOPLASTIC AGENT; TP53 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CARCINOGENESIS; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; FEMALE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SYNTHESIS; SENESCENCE; STROMA CELL; TREATMENT RESPONSE; ADENOCARCINOMA; ANIMAL; BREAST TUMOR; GENETICS; MOUSE MUTANT; MUTATION; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; FEMALE; FIBROBLASTS; HUMANS; MALE; MICE; MICE, SCID; MUTATION; PROSTATIC NEOPLASMS; STROMAL CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 47049117155     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23546     Document Type: Article

References (19)

1. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264:169-84.
2. Tlsty TD, Hein PW. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001;11:54-9.
3. Olumi A, Grossfeld G, Hayward S, Carroll P, Tlsty T, Cunha G. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostate epithelium. Cancer Res 1999;59:5002-11.
4. Kiaris H, Chatzistamou CH, Kalofoutis H, Koutselini C, Piperi A. Kalofoutis. Tumor-stroma interactions in carcinogenesis: basic aspects and perspectives. Mol Cell Biochem 2004;261:117-22.
5. Kurose K, Gilley S, Matsumoto PH, Watson XP, Zhou C. Eng frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002;32:355-7.
6. Hill R, Song Y, Cardiff RD, Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2006;123:1001-11.
7. Bierie B, Moses HL. Under pressure: stromal fibroblasts change their ways. Cell 2005;123:985-7.
8. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000;60:2562-6.
9. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A, Kalofoutis A. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 2005;65:1627-30.
10. Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 2006;66:10671-6.
11. Khwaja FW, Svoboda P, Reed M, Pohl J, Pyrzynska B, Van Meir EG. Proteomic identification of the wt-p53-regulated tumor cell secretome. Oncogene 2006;25:7650-61.
12. Lowe SW. Cancer therapy and p53. Curr Opin Oncol 1995;7:547-53.
13. Weller M. Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res 1998;292:435-45.
14. Burdelya LG, Komarova EA, Hill JE, Browder T, Tararova ND, Mavrakis L, DiCorleto PE, Folkman J, Gudkov AV. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res 2006;66:9356-61.
15. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-7.
16. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004;101:4966-71.
17. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007;445:656-60.
18. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001;98:12072-7.
19. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995;377:552-7.